Skip to main content

Advertisement

ADVERTISEMENT

News

News
01/05/2023
Jolynn Tumolo
An angiotensin-converting enzyme inhibitor is being recalled due to the presence of a nitrosamine impurity above the acceptable daily intake limit.
An angiotensin-converting enzyme inhibitor is being recalled due to the presence of a nitrosamine impurity above the acceptable daily intake limit.
An angiotensin-converting enzyme...
01/05/2023
Pharmacy Learning Network

Advertisement

News
01/05/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription anticonvulsant used to treat partial-onset seizures.
A Class II recall has been issued for a prescription anticonvulsant used to treat partial-onset seizures.
A Class II recall has been...
01/05/2023
Pharmacy Learning Network
News
01/05/2023

Michelle Andrews, Kaiser Health News

Michelle Andrews, Kaiser Health News ...
The law is intended to bolster the number of naloxone prescriptions and reduce stigma-related barriers for patients who take opioids.
The law is intended to bolster the number of naloxone prescriptions and reduce stigma-related barriers for patients who take opioids.
The law is intended to bolster...
01/05/2023
Pharmacy Learning Network
News
01/04/2023
Jolynn Tumolo
Aurolife Pharma is recalling a prescription medication used to treat peptic ulcers.
Aurolife Pharma is recalling a prescription medication used to treat peptic ulcers.
Aurolife Pharma is recalling a...
01/04/2023
Pharmacy Learning Network

Advertisement

News
01/03/2023
Maria Asimopoulos
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the...
01/03/2023
Pharmacy Learning Network
News
12/21/2022
Jolynn Tumolo
A Class I recall of sodium bicarbonate injection 8.4% has been expanded to include 14 additional lots.
A Class I recall of sodium bicarbonate injection 8.4% has been expanded to include 14 additional lots.
A Class I recall of sodium...
12/21/2022
Pharmacy Learning Network
News
12/21/2022

Liz Szabo and Arthur Allen, Kaiser Health News

Liz Szabo and Arthur Allen, Kaiser He...
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network

Advertisement

News
12/12/2022

Aneri Pattani and Rae Ellen Bichell, Kaiser Health News

Aneri Pattani and Rae Ellen Bichell, ...
Some experts say settlement funds intended to bolster health services for people with opioid use disorder are not being distributed in sufficient sums to rural areas.
Some experts say settlement funds intended to bolster health services for people with opioid use disorder are not being distributed in sufficient sums to rural areas.
Some experts say settlement...
12/12/2022
First Report Managed Care
News
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
News
12/08/2022

Hannah Recht, Kaiser Health News

Hannah Recht, Kaiser Health News ...
Health experts say older adults and uninsured individuals may experience substantial access barriers when the COVID-19 treatment moves to the private market in 2023.
Health experts say older adults and uninsured individuals may experience substantial access barriers when the COVID-19 treatment moves to the private market in 2023.
Health experts say older adults...
12/08/2022
Pharmacy Learning Network

Advertisement